Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

authors

  • Clement Paul M.J.
  • Dirven Linda
  • Eoli Marica
  • Sepulveda-Sanchez Juan
  • Walenkamp Annemiek M.E.
  • Frenel Jean
  • Franceschi Enrico
  • Weller Michael
  • Chinot Olivier
  • de Vos Filip Y.F.L.
  • Whenham Nicolas
  • Sanghera Paul
  • Looman Jim
  • Kundu Madan
  • Peter de Geus Jan
  • Nuyens Sarah
  • Spruyt Maarten
  • Gorlia Thierry
  • Coens Corneel
  • Golfinopoulos Vassilis
  • Reijneveld Jaap
  • van den Bent Martin

document type

ART

more information